Growth Metrics

West Pharmaceutical Services (WST) Intangibles (2016 - 2026)

West Pharmaceutical Services has reported Intangibles over the past 18 years, most recently at $7.0 million for Q1 2026.

  • Quarterly Intangibles fell 30.0% to $7.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.0 million through Mar 2026, down 30.0% year-over-year, with the annual reading at $7.7 million for FY2025, 28.7% down from the prior year.
  • Intangibles was $7.0 million for Q1 2026 at West Pharmaceutical Services, down from $7.7 million in the prior quarter.
  • Over five years, Intangibles peaked at $21.8 million in Q1 2022 and troughed at $7.0 million in Q1 2026.
  • The 5-year median for Intangibles is $13.9 million (2024), against an average of $13.9 million.
  • Biggest five-year swings in Intangibles: tumbled 30.65% in 2022 and later fell 13.26% in 2023.
  • Tracing WST's Intangibles over 5 years: stood at $18.4 million in 2022, then decreased by 17.93% to $15.1 million in 2023, then decreased by 28.48% to $10.8 million in 2024, then decreased by 28.7% to $7.7 million in 2025, then decreased by 9.09% to $7.0 million in 2026.
  • According to Business Quant data, Intangibles over the past three periods came in at $7.0 million, $7.7 million, and $8.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.